According to Oryzon Genomics's latest financial reports the company has โน8.04 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $โน7.52 B | 16.82% |
2022-12-31 | $โน6.44 B | 7.24% |
2021-12-31 | $โน6.00 B | -12.05% |
2020-12-31 | $โน6.83 B | 39.87% |
2019-12-31 | $โน4.88 B | 35.29% |
2018-12-31 | $โน3.60 B | 36.84% |
2017-12-31 | $โน2.63 B | 62.37% |
2016-12-31 | $โน1.62 B | -18.97% |
2015-12-31 | $โน2.00 B | 87.22% |
2014-12-31 | $โน1.07 B |